Literature DB >> 15597752

Intracarotid Amytal memory test and hippocampal magnetic resonance imaging volumetry: validity of the Wada test as an indicator of hippocampal integrity among candidates for epilepsy surgery.

Aaron A Cohen-Gadol1, Michael Westerveld, Juan Alvarez-Carilles, Dennis D Spencer.   

Abstract

OBJECT: Intracarotid Amytal testing (the Wada test) has been used to lateralize language and identify patients who may be at risk for memory impairment after temporal lobectomy. The goal of this study was to determine the validity of the Wada test in the assessment of pathological conditions of the hippocampus among candidates for epilepsy surgery. The authors examined the correlation between the functional integrity of the hippocampus, measured using the Wada test, and quantitative measures of hippocampal pathology, determined by obtaining volumetric measurements of the hippocampus with the aid of magnetic resonance (MR) imaging.
METHODS: The authors reviewed the relationship between memory scores on the Wada test and hippocampal volumes measured on preoperative MR images in 76 patients who underwent anteromedial temporal lobectomy and amygdalohippocampectomy for the treatment of medically refractory temporal lobe epilepsy. The data were analyzed with respect to their usefulness in lateralizing the seizure focus and predicting the long-term postoperative memory outcome. Right and left hippocampal volume measurements did not correlate with one another (p > 0.1). Similarly, following a left carotid artery injection of Amytal the patients' right hemisphere memory was not significantly related to their left hemisphere memory on the Wada test (p'> 0.1). On the other hand, the patients' right hemisphere memory significantly correlated with their right hippocampal volume (r = 0.51; p < 0.001) and their left hemisphere memory significantly correlated with their left hippocampal volume (r = 0.51; p < 0.001). Both right and left hemisphere memory scores correlated with the hippocampal volumetry ratio (r = 0.47 and r = 0.45, respectively; both p < 0.001). Lateralization of a seizure focus based on hippocampal volumetry results was significantly related to lateralization based on the results of the Wada test (r = 0.49; p < 0.01). The disparity between the Wada memory scores on ipsilateral and contralateral sides was significantly and inversely related to the change in verbal memory following temporal lobectomy (r = -0.28; p < 0.02). The preoperative hippocampal volumetry ratio also significantly and inversely correlated with the change in verbal memory after surgery (r = -0.31; p < 0.01).
CONCLUSIONS: The Wada memory test may be a valuable method of measuring the functional integrity of the hippocampus. The systematic study of MR imaging-acquired morphological data and Wada-acquired neuropsychological data may increase our understanding of the location of material-specific memory and the selection of eligible candidates for epilepsy surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15597752     DOI: 10.3171/jns.2004.101.6.0926

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Use of preoperative functional MRI to predict verbal memory decline after temporal lobe epilepsy surgery.

Authors:  Jeffrey R Binder; David S Sabsevitz; Sara J Swanson; Thomas A Hammeke; Manoj Raghavan; Wade M Mueller
Journal:  Epilepsia       Date:  2008-04-24       Impact factor: 5.864

2.  Classic hippocampal sclerosis and hippocampal-onset epilepsy produced by a single "cryptic" episode of focal hippocampal excitation in awake rats.

Authors:  Braxton A Norwood; Argyle V Bumanglag; Francesco Osculati; Andrea Sbarbati; Pasquina Marzola; Elena Nicolato; Paolo F Fabene; Robert S Sloviter
Journal:  J Comp Neurol       Date:  2010-08-15       Impact factor: 3.215

Review 3.  Functional MRI is a valid noninvasive alternative to Wada testing.

Authors:  Jeffrey R Binder
Journal:  Epilepsy Behav       Date:  2010-09-17       Impact factor: 2.937

Review 4.  The neurobiology of cognitive disorders in temporal lobe epilepsy.

Authors:  Brian Bell; Jack J Lin; Michael Seidenberg; Bruce Hermann
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

Review 5.  Preoperative prediction of verbal episodic memory outcome using FMRI.

Authors:  Jeffrey R Binder
Journal:  Neurosurg Clin N Am       Date:  2011-04       Impact factor: 2.509

6.  Language Lateralization in Patients with Temporal Lobe Epilepsy : A Comparison between Volumetric Analysis and the Wada Test.

Authors:  Young-Min Oh; Eun-Jeong Koh
Journal:  J Korean Neurosurg Soc       Date:  2009-06-30

7.  Cortical Activation Through Passive-Motion Functional MRI.

Authors:  A F Choudhri; R M Patel; A Siddiqui; M T Whitehead; J W Wheless
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

8.  Hippocampal volumetry and functional MRI of memory in temporal lobe epilepsy.

Authors:  Dawn Mechanic-Hamilton; Marc Korczykowski; Paul A Yushkevich; Kathy Lawler; John Pluta; Simon Glynn; Joseph I Tracy; Ronald L Wolf; Michael R Sperling; Jacqueline A French; John A Detre
Journal:  Epilepsy Behav       Date:  2009-08-11       Impact factor: 2.937

Review 9.  Functional connectivity of hippocampus in temporal lobe epilepsy depends on hippocampal dominance: a systematic review of the literature.

Authors:  Camille K Milton; Christen M O'Neal; Andrew K Conner
Journal:  J Neurol       Date:  2021-02-10       Impact factor: 4.849

10.  Wada test results contribute to the prediction of change in verbal learning and verbal memory function after temporal lobe epilepsy surgery.

Authors:  Nadine Conradi; Friederike Rosenberg; Susanne Knake; Louise Biermann; Anja Haag; Iris Gorny; Anke Hermsen; Viola von Podewils; Marion Behrens; Marianna Gurschi; Richard du Mesnil de Rochemont; Katja Menzler; Sebastian Bauer; Susanne Schubert-Bast; Christopher Nimsky; Jürgen Konczalla; Felix Rosenow; Adam Strzelczyk
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.